Unusual Stomach Mass: Gastric Metastasis of Malignant Leiomyosarcoma

Document Type

Conference Proceeding

Publication Date

10-2022

Publication Title

American Journal of Gastroenterology

Abstract

Introduction:

Metastases in the stomach are rare findings, and likely represent a progressive malignant disease. With reported incidence of 0.2%-0.7%, the tumor can spread through hematogenous, lymphatic direct and peritoneal dissemination. Gastric metastases of leiomyosarcoma (LMS), a rare malignant mesenchymal smooth muscle tumor, have only been documented in a handful of case reports. We present a case of metastatic leiomyosarcoma in the stomach presenting with gastrointestinal bleeding.

Case Description/Methods:

A 64-year-old male with history of metastatic LMS of his left lower extremity came with melena for 3 days. Hemoglobin on presentation was 8.7 g/dl from his baseline of 13-14g/dl. He was diagnosed with grade 3 LMS 3 years ago, involving femoral vessel wall and muscle of his left thigh. He underwent radical excision without any adjuvant chemo and radiotherapy despite recommendations. He subsequently developed metastasis to the lung two years later at which time he started chemotherapy. An esophagogastroduodenoscopy revealed a 6 mm mucosal nodule and a 3 cm mass with a clean based ulcer in the body of stomach. Biopsy, however, was negative for malignancy. He then underwent endoscopic ultrasound guided biopsy for cytology which revealed malignant spindle cell neoplasm in the background of lymphoid tissue consistent with metastatic LMS (Figure 1).

Discussion:

LMS, a malignant tumor of smooth muscle origin, represents 20%-30% of soft tissue sarcomas. Predominantly uterine in origin, it can arise from the peritoneum, extremities, and blood vessels. Primary gastric LMS has also been reported in literature, but they are extremely rare and now are considered a type of gastrointestinal stromal tumor. LMS has a rapid tendency to metastasize, with lung, peritoneum, bone, and liver being common targets. Some rare cases of LMS metastasizing to pancreas, stomach and oral cavity have been reported. In general, metastases to the stomach are uncommon. The most common gastric metastases come from breast, lung, renal cell cancer and malignant melanoma. Metastasis of LMS to gastric mucosa has been limited to only a handful of case reports with primary tumors arising from kidney, uterus, and broad ligaments. The lesions are described as nodules, submucosal tumors, and ulcerative lesions, most of which are asymptomatic but can present as GI bleeding and abdominal pain. These metastases typically portray a poor prognosis. Local excision of the primary lesion with hormonal therapy and chemotherapy is considered standard treatment.

Volume

117

Issue

10 Suppl

First Page

e2310

Comments

American College of Gastroenterology Annual Scientific Meeting, October 21-26, 2022, Charlotte, NC.

Last Page

e2311

DOI

10.14309/01.ajg.0000871380.67074.48

Link to Full Text

Share

COinS